Corbus Pharmaceuticals Announces Closing of $94.5 Million
NORWOOD, Mass., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), a precision oncology company...
Terns Pharmaceuticals Reports Inducement Grant to New
FOSTER CITY, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
Tempest Reports Inducement Grant Under Nasdaq Listing Rule
BRISBANE, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine...
Olema Oncology Reports Inducement Grants Under Nasdaq
SAN FRANCISCO, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused...
Brunswick Exploration Grants Stock Options
MONTREAL, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company”) wishes to announce that...
Canadian Large Cap Leaders Split Corp. Files Final
TORONTO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint”) is pleased to announce that Canadian Large Cap Leaders...
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq
BOSTON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare...
Sigyn Therapeutics Completes Reverse Stock Split
SAN DIEGO, CA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire –Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: “SIGYD”, “SIGY”), a...
Cartier starts 25,000 m drilling program on the Chimo Mine
VAL-D’OR, Quebec, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Cartier Resources Inc. (TSXV: ECR) (“Cartier” or the “Company”) starts a 25,000 m exploration drilling...
Nasdaq Determines TransCode Therapeutics Compliance with
BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively...
Constellation Software Inc. Enters Amended and Restated
TORONTO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) announced today that it has completed an amendment and restatement of...
Morien Announces Renewal of Normal Course Issuer Bid
HALIFAX, Nova Scotia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Morien Resources Corp. ("Morien" or the "Company") (TSX-V:MOX), is pleased to announce that...
